ArticleJournal of pain research2025
Comparison of Opioid Consumption During Target Controlled Infusion (TCI) Guided By Nociception Level Index (NOL) or Standard Care Undergoing Intracranial Tumor Surgery.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This prospective, randomized controlled study aims to compare opioid doses in patients undergoing intracranial tumor surgery managed with Total Intravenous Anesthesia using Target Controlled Infusion (TIVA-TCI) combined with Nociception Level (NOL) monitoring. The NOL index, an artificial intelligence-driven multiparameter index, integrates physiological signals such as heart rate, skin conductance, and photoplethysmography to provide an objective measure of nociception and guide personalized opioid administration. Additionally, the study evaluates the consumption of hypnotic drugs, hemodynamic parameters, variability in the NOL index, and changes in Heart Rate (HR) in the study group patients who received NOL monitoring following severe noxious stimuli. Patients and Methods: The study involved 50 ASA II-III patients undergoing intracranial tumor surgery, with 25 in the standard care guided group and 25 in the NOL guided group. The control group received standard monitoring while NOL monitoring added in the study group. Propofol and remifentanil were titrated to maintain hemodynamic parameters or NOL values. Hemodynamic parameters, propofol and remifentanil doses were recorded and compared between groups. NOL index changes before and after noxious stimuli were compared with HR changes. Results: No significant differences were found in demographic data between the two groups. The remifentanil dose administered was similar in both groups. The study group received a higher dose of propofol. However, the control group had a longer duration of operation. The NOL index showed a significantly higher change after severe noxious stimuli compared to Heart Rate, indicating greater sensitivity. Conclusion: This study compares NOL index monitoring to standard monitoring during intracranial tumor surgery. The results indicate that NOL monitoring is reliable in detecting and monitoring nociception events compared to heart rate changes. However, it does not lead to a significant reduction in opioid dose administration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.